Work

FDA Analysis: Impact of Body Mass Index (BMI) on Outcomes in Relapsed-Refractory Multiple Myeloma

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-130551

Authors: Rachel Ershler, Bindu Kanapuru, Yutao Gong, Urvi A Shah, Sham Mailankody, Ola Landgren, Marc Theoret, Nicole J Gormley, Ann T. Farrell, Richard Pazdur

Institutions: United States Food and Drug Administration, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2988259115

Cites:

Cited by:

Related to: 10